Our partner is a clinical-stage biopharmaceutical company focused n the development and ultimate commercialization of novel bile acid modulators to treat orphan pediatric liver disease and other liver and gastrointestinal disease and disorders. The clinical pipeline includes a Phase 3 program along with several earlier phase project that are designed to act locally to retore normal bile acid level and treat disease and disorders associated with irregularities in bile acid biology.

This hire was responsible for providing leadership and driving the quality management process for the company on global basis. This included management and oversight of all quality assurance and quality control functions including those related to regulated research and development activities as well as commercial activities, particularly as they pertained to the company’s drug substances and dosage forms.